Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 6/20 | 0.42 |
| ▸ | ARG1 | P05089 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 6/20 | 0.36 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.33 |
| ▸ | PLAU | P00749 | 1/20 | 0.33 |
| ▸ | PLAUR | Q03405 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL435439 | 0.85 | DPP4 (0.49) | DPP4ARG1DPP7DPP8DPP9 | |
| SCHEMBL30357425 | 0.81 | DPP4 (0.50) | DPP4ARG1DPP7DPP8 | |
| SCHEMBL20163928 | 0.80 | DPP4 (0.41) | DPP4RAB9ADPP7DPP8DPP9 | |
| SCHEMBL20163929 | 0.80 | DPP4 (0.41) | DPP4RAB9ADPP7DPP8DPP9 | |
| SCHEMBL16310466 | 0.79 | DPP4 (0.49) | DPP4ARG1DPP7DPP8 | |
| SCHEMBL3346333 | 0.79 | DPP4 (0.49) | DPP4ARG1DPP7DPP8 | |
| SCHEMBL22413877 | 0.77 | DPP7 (0.35) | DPP4RAB9ADPP7DPP8LMNA | |
| SCHEMBL4702393 | 0.76 | HSD17B10 (0.46) | DPP4KDM4E | |
| SCHEMBL24964924 | 0.75 | RAB9A (0.37) | RAB9ALMNA | |
| Trifluoroacetic Acid SCHEMBL20163711 | 0.74 | DPP8 (0.45) | DPP4RAB9ADPP7DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026641-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND COMPRISING HIGHLY STERICALLY HINDERED AMINO ACID | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026641-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND COMPRISING HIGHLY STERICALLY HINDERED AMINO ACID | DNPEP, VIP, NPEPPS | DPP4 123/4885ARG1 303/4885RAB9A 1443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.